首页> 外文期刊>Tetrahedron >A Garratt-Braverman cyclization route towards the synthesis of phenanthridine derivatives and their DNA-binding studies
【24h】

A Garratt-Braverman cyclization route towards the synthesis of phenanthridine derivatives and their DNA-binding studies

机译:葛兰胺型环化途径朝向合成菲锭衍生物及其DNA结合研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Garratt-Braverman cyclization has been employed to synthesize a series of dihydroisofuran fused phenanthridine derivatives. The established protocol proposes a simpler synthetic alternative to have access to these therapeutically relevant cytotoxic scaffolds. Single crystal X-ray data unambiguously confirmed the structures of the synthesized phenanthridine derivatives. UV-Vis absorption titration with calf thymus DNA followed by fluorescence-based competitive ethidium bromide displacement assay established the synthesized target compounds as potent DNA-intercalating agents with intrinsic binding constant of the range 10(3)-10(5). Results obtained from the molecular docking further justified the spectroscopically obtained results. (C) 2019 Elsevier Ltd. All rights reserved.
机译:Garratt-Braverman环化已被用于合成一系列二氢呋喃融合菲素衍生物。 建立的协议提出了一种更简单的合成替代方案,可以访问这些治疗性相关的细胞毒性支架。 单晶X射线数据明确证实了合成的菲锭衍生物的结构。 用小牛胸腺DNA的UV-Vis吸收滴定,然后进行荧光的竞争性乙氨乙锭位移测定,将合成的靶化合物与具有型号10(3)-10(5)的内在结合常数的有效的DNA嵌入剂建立。 从分子对接获得的结果进一步证明了光谱所得的结果。 (c)2019 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号